MyFinsight
Home
About
Contact
Download
Download image
Net loss
-$1,823,351
Total other income
(expense), net
-$1,122,181
Loss from operations
-$701,170
Change in the fair value
of warrant...
-$76,871
Change in fair value of
deferred underwriting...
$560,000
Loss on exchange of
common stock for...
-$1,740,000
Total operating
expenses
$701,170
Interest expense,
related parties
$19,052
General and
administrative
$701,170
Back
Back
Income Statement
source: myfinsight.com
limn: the income statement
Liminatus Pharma, Inc. (LIMN)
Liminatus Pharma, Inc. (LIMN)